This observation raised the possibility that 4-deoxy-4-X-Gal mimetics could be used as antimetabolite drugs in cancer cells such as GBM that express Glut3/14 and the enzymes of the Leloir pathway [5]. Here, SLC2A3 is linked to cancer.